Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03088904 · ClinicalTrials.gov registry record · Phase 1
Genetic and Environmental Factors in the Response to Influenza Vaccination
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 109
- Enrollment target
NCT03088904: Completed Phase 1 study, sponsored by Stanford University.
NCT03088904 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03088904, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 109 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate and compare the immune responses to influenza vaccination in monozygotic (identical) and dizygotic (fraternal) twins to determine the roles of genetics and environment in the response to flu vaccination.
Interventions
- BIOLOGICAL FluMist® Quadrivalent
- BIOLOGICAL Fluzone® Quadrivalent vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2014-10-03 |
| Est. Completion | 2018-12-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03088904
The ClinicalTrials.gov registry entry for NCT03088904 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FluMist® Quadrivalent is the first listed.
NCT03088904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03088904 about?
NCT03088904 is a clinical study titled "Genetic and Environmental Factors in the Response to Influenza Vaccination". The purpose of the study is to investigate and compare the immune responses to influenza vaccination in monozygotic (identical) and dizygotic (fraternal) twins to determine the roles of genetics and environment in the response to flu vaccination.
What is the current status of trial NCT03088904?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 109 participants. The study started on 2014-10-03. Estimated completion is 2018-12-12.
What interventions are being tested in trial NCT03088904?
The interventions under investigation include: FluMist® Quadrivalent (BIOLOGICAL), Fluzone® Quadrivalent vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT03088904?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.